Executive Summary: The global Pharmacogenetic Testing market was valued at USD 610.34 million in 2024 and is expected to reach USD 1346.87 million by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 10.4%, primarily driven by the increasing adoption of personalized medicine, This growth is driven by factors such as the advancements in geno... https://www.databridgemarketresearch.com/reports/global-pharmacogenetic-testing-market